The Armed Forces Institute of Regenerative Medicine (AFIRM) is a multi-institutional, interdisciplinary network working to develop advanced treatment options for our severely wounded servicemen and women. The AFIRM is managed and funded through the US Army Medical Research and Materiel Command (MRMC); with additional funding from the US Navy, Office of Naval Research; the US Air Force, Office of the Surgeon General; the National Institutes of Health; the Veterans Administration; the Department of Defense, Health Affairs and local public and private matching funding.
AFIRM-Funded Clinical Trials. The AFIRM conducts clinical trials so that research can be translated from the laboratory to the clinic. For more information, click on the links below.
Current Clinical Trials:This website provides an introduction to the Armed Forces Institute of Regenerative Medicine (AFIRM) and contains official Government information.
Its use is intended for members of the general public, news media and Military Health System beneficiaries.
Please address questions or concerns about this website to the USAMRMC Public Affairs Office at usamrmcwebmaster@amedd.army.mil or by telephone at 301-619-2736
Last Modified Date: 17 May 2012
April 18, 2012
Read about the Armed Forces Institute of Regenerative Medicine – II (AFIRM II) on the Grants.gov website at:
Postdoctoral Research Opportunities in Extremity Trauma & Regenerative Medicine at the US Army Institute of Surgical Research
The Extremity Trauma and Regenerative Medicine Task Area at the United States Army Institute of Surgical Research (USAISR) is seeking candidates for postdoctoral positions.
Qualified candidates must be highly motivated, independent individuals with a PhD in bioengineering, physiology, cell biology, microbiology, or a related field ...